BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31469745)

  • 41. What Is the Association Between Hospital Volume and Complications After Revision Total Joint Arthroplasty: A Large-database Study.
    Ricciardi BF; Liu AY; Qiu B; Myers TG; Thirukumaran CP
    Clin Orthop Relat Res; 2019 May; 477(5):1221-1231. PubMed ID: 30998640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 30-day hospital readmission following otolaryngology surgery: Analysis of a state inpatient database.
    Graboyes EM; Kallogjeri D; Saeed MJ; Olsen MA; Nussenbaum B
    Laryngoscope; 2017 Feb; 127(2):337-345. PubMed ID: 27098654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence and risk factors for venous thromboembolism events after different routes of pelvic organ prolapse repairs.
    Chong W; Bui AH; Menhaji K
    Am J Obstet Gynecol; 2020 Aug; 223(2):268.e1-268.e26. PubMed ID: 32413430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 90-day Readmission in Elective Primary Lumbar Spine Surgery in the Inpatient Setting: A Nationwide Readmissions Database Sample Analysis.
    Rubel NC; Chung AS; Wong M; Lara NJ; Makovicka JL; Arvind V; Chang MS; Cho SK
    Spine (Phila Pa 1976); 2019 Jul; 44(14):E857-E864. PubMed ID: 30817732
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Which Clinical and Patient Factors Influence the National Economic Burden of Hospital Readmissions After Total Joint Arthroplasty?
    Kurtz SM; Lau EC; Ong KL; Adler EM; Kolisek FR; Manley MT
    Clin Orthop Relat Res; 2017 Dec; 475(12):2926-2937. PubMed ID: 28108823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dialysis is an independent risk factor for perioperative adverse events, readmission, reoperation, and mortality for patients undergoing elective spine surgery.
    Ottesen TD; McLynn RP; Zogg CK; Shultz BN; Ondeck NT; Bovonratwet P; Bellamkonda KS; Rubin LE; Grauer JN
    Spine J; 2018 Nov; 18(11):2033-2042. PubMed ID: 30077772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Costs Associated With Lobectomy for Lung Cancer: An Analysis Merging STS and Medicare Data.
    Medbery RL; Fernandez FG; Kosinski AS; Tong BC; Furnary AP; Feng L; Onaitis M; Boffa D; Wright CD; Cowper P; Jacobs JP; Putnam JB; Habib RH
    Ann Thorac Surg; 2021 Jun; 111(6):1781-1790. PubMed ID: 33188754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for 30-day readmission in patients undergoing ventral hernia repair.
    Lovecchio F; Farmer R; Souza J; Khavanin N; Dumanian GA; Kim JY
    Surgery; 2014 Apr; 155(4):702-10. PubMed ID: 24612622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Readmission After Pediatric Cardiothoracic Surgery: An Analysis of The Society of Thoracic Surgeons Database.
    Kogon BE; Oster ME; Wallace A; Chiswell K; Hill KD; Cox ML; Jacobs JP; Pasquali S; Karamlou T; Jacobs ML
    Ann Thorac Surg; 2019 Jun; 107(6):1816-1823. PubMed ID: 30742819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. When good operations go bad: The additive effect of comorbidity and postoperative complications on readmission after pulmonary lobectomy.
    Jean RA; Chiu AS; Boffa DJ; Detterbeck FC; Blasberg JD; Kim AW
    Surgery; 2018 Aug; 164(2):294-299. PubMed ID: 29801731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathological lymph node involvement is not a predictor of adverse outcomes in patients undergoing thoracoscopic lobectomy for lung cancer†.
    Abah U; Casali G; Batchelor TJP; Internullo E; Krishnadas R; Joshi N; Egbulonu S; Warden F; Bruno VD; West DG
    Eur J Cardiothorac Surg; 2018 Feb; 53(2):342-347. PubMed ID: 28958031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relative incremental costs of complications of lobectomy for stage I non-small cell lung cancer.
    Geller AD; Zheng H; Mathisen DJ; Wright CD; Lanuti M
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1804-1811. PubMed ID: 29254638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes after lobectomy using thoracoscopy vs thoracotomy: a comparative effectiveness analysis utilizing the Nationwide Inpatient Sample database.
    Paul S; Sedrakyan A; Chiu YL; Nasar A; Port JL; Lee PC; Stiles BM; Altorki NK
    Eur J Cardiothorac Surg; 2013 Apr; 43(4):813-7. PubMed ID: 22826474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. All grades of severity of postoperative adverse events are associated with prolonged length of stay after lung cancer resection.
    Zhang Z; Mostofian F; Ivanovic J; Gilbert S; Maziak DE; Shamji FM; Sundaresan S; Villeneuve PJ; Seely AJE
    J Thorac Cardiovasc Surg; 2018 Feb; 155(2):798-807. PubMed ID: 29103816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unplanned 30-day readmission in patients with diabetic foot wounds treated in a multidisciplinary setting.
    Holscher CM; Hicks CW; Canner JK; Sherman RL; Malas MB; Black JH; Mathioudakis N; Abularrage CJ
    J Vasc Surg; 2018 Mar; 67(3):876-886. PubMed ID: 29017807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pneumonectomy for lung cancer: contemporary national early morbidity and mortality outcomes.
    Thomas PA; Berbis J; Baste JM; Le Pimpec-Barthes F; Tronc F; Falcoz PE; Dahan M; Loundou A;
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):73-82. PubMed ID: 25439468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Readmission following primary surgery for larynx and oropharynx cancer in the elderly.
    Chaudhary H; Stewart CM; Webster K; Herbert RJ; Frick KD; Eisele DW; Gourin CG
    Laryngoscope; 2017 Mar; 127(3):631-641. PubMed ID: 27659029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unplanned Readmission After Lung Resection: Complete Follow-Up in a 1-Year Cohort With Identification of Associated Risk Factors.
    Dickinson KJ; Taswell JB; Allen MS; Blackmon SH; Nichols FC; Shen R; Wigle DA; Cassivi SD
    Ann Thorac Surg; 2017 Apr; 103(4):1084-1091. PubMed ID: 27993376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors for 30-day readmission after pulmonary resection for lung cancer.
    Quero-Valenzuela F; Piedra-Fernández I; Martínez-Ceres M; Romero-Palacios PJ; Sánchez-Palencia A; De Guevara AC; Torné-Poyatos P
    J Surg Oncol; 2018 May; 117(6):1239-1245. PubMed ID: 29355966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for 30-day hospital readmission among general surgery patients.
    Kassin MT; Owen RM; Perez SD; Leeds I; Cox JC; Schnier K; Sadiraj V; Sweeney JF
    J Am Coll Surg; 2012 Sep; 215(3):322-30. PubMed ID: 22726893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.